MA23860A1 - Derives de benzylamine substitues se liant specifiquement aux recepteurs du neuropeptide y1 et compositions les contenant - Google Patents
Derives de benzylamine substitues se liant specifiquement aux recepteurs du neuropeptide y1 et compositions les contenantInfo
- Publication number
- MA23860A1 MA23860A1 MA24226A MA24226A MA23860A1 MA 23860 A1 MA23860 A1 MA 23860A1 MA 24226 A MA24226 A MA 24226A MA 24226 A MA24226 A MA 24226A MA 23860 A1 MA23860 A1 MA 23860A1
- Authority
- MA
- Morocco
- Prior art keywords
- neuropeptide
- receptors
- compositions containing
- specifically binding
- substituted benzylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47838395A | 1995-06-07 | 1995-06-07 | |
| US48497495A | 1995-06-07 | 1995-06-07 | |
| PCT/US1995/014472 WO1996014307A1 (en) | 1994-11-07 | 1995-11-07 | Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA23860A1 true MA23860A1 (fr) | 1996-12-31 |
Family
ID=27045885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA24226A MA23860A1 (fr) | 1995-06-07 | 1996-05-08 | Derives de benzylamine substitues se liant specifiquement aux recepteurs du neuropeptide y1 et compositions les contenant |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0833823A1 (de) |
| JP (1) | JPH10507203A (de) |
| AU (1) | AU5578796A (de) |
| BR (1) | BR9609334A (de) |
| CA (1) | CA2220958A1 (de) |
| CO (1) | CO4700426A1 (de) |
| IL (1) | IL117997A0 (de) |
| MA (1) | MA23860A1 (de) |
| PE (1) | PE34297A1 (de) |
| TR (1) | TR199600382A2 (de) |
| WO (1) | WO1996040660A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3671897A (en) * | 1996-07-23 | 1998-02-10 | Neurogen Corporation | Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| EP0915860A1 (de) * | 1996-07-23 | 1999-05-19 | Neurogen Corporation | Einige amido- und ammo-substituierte benzylaminderivate: eine neue klasse von neuropeptid y1 spezifische ligande |
| WO1998003492A1 (en) * | 1996-07-23 | 1998-01-29 | Neurogen Corporation | Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| US6048900A (en) * | 1998-02-13 | 2000-04-11 | Bayer Corporation | Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists |
| JP2000510164A (ja) * | 1997-02-14 | 2000-08-08 | バイエル・コーポレーシヨン | 選択的神経ペプチドｙ受容体アンタゴニストとしてのアミド誘導体 |
| AU6267198A (en) * | 1997-02-14 | 1998-09-08 | Bayer Corporation | Amides as npy5 receptor antagonists |
| US6245817B1 (en) | 1997-02-14 | 2001-06-12 | Bayer Corporation | NPY5 receptor antagonists and methods for using same |
| US6420130B1 (en) | 1998-12-14 | 2002-07-16 | Aurora Biosciences Corporation | Optical molecular sensors for cytochrome P450 activity |
| CA2352631A1 (en) * | 1998-12-14 | 2000-06-22 | Aurora Biosciences Corporation | Optical molecular sensors for cytochrome p450 activity |
| TW200307539A (en) * | 2002-02-01 | 2003-12-16 | Bristol Myers Squibb Co | Cycloalkyl inhibitors of potassium channel function |
| JP4806628B2 (ja) | 2003-05-05 | 2011-11-02 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤 |
| EP2338490A3 (de) | 2003-11-03 | 2012-06-06 | Probiodrug AG | Zusammenstellungen zur Behandlung von neuronalen Erkrankungen |
| BRPI0507485A (pt) | 2004-02-05 | 2007-07-10 | Probiodrug Ag | inibidores novos de glutaminil ciclase |
| EP1834953A1 (de) | 2006-03-14 | 2007-09-19 | Ranbaxy Laboratories Limited | Tetrahydropyran-Derivate als 5-Lipoxygenase-Hemmer |
| WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| EP2117540A1 (de) | 2007-03-01 | 2009-11-18 | Probiodrug AG | Neue verwendung von glutaminyl-cyclase-hemmern |
| JP5667440B2 (ja) | 2007-04-18 | 2015-02-12 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体 |
| SG178953A1 (en) | 2009-09-11 | 2012-04-27 | Probiodrug Ag | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
| US9181233B2 (en) | 2010-03-03 | 2015-11-10 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| AU2011226074B2 (en) | 2010-03-10 | 2015-01-22 | Vivoryon Therapeutics N.V. | Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5) |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4845221A (en) * | 1988-04-15 | 1989-07-04 | American Home Products Corporation | Serotonergic substituted piperazinyl tetralins |
| KR0173310B1 (ko) * | 1989-04-22 | 1999-02-01 | 폴 에이 리쳐 | 피페라진 유도체 |
-
1996
- 1996-04-22 IL IL11799796A patent/IL117997A0/xx unknown
- 1996-04-26 BR BR9609334A patent/BR9609334A/pt not_active Application Discontinuation
- 1996-04-26 JP JP9500490A patent/JPH10507203A/ja active Pending
- 1996-04-26 EP EP96913198A patent/EP0833823A1/de not_active Withdrawn
- 1996-04-26 AU AU55787/96A patent/AU5578796A/en not_active Abandoned
- 1996-04-26 CA CA002220958A patent/CA2220958A1/en not_active Abandoned
- 1996-04-26 WO PCT/US1996/005843 patent/WO1996040660A1/en not_active Application Discontinuation
- 1996-05-08 PE PE1996000325A patent/PE34297A1/es not_active Application Discontinuation
- 1996-05-08 MA MA24226A patent/MA23860A1/fr unknown
- 1996-05-08 CO CO96022963A patent/CO4700426A1/es unknown
- 1996-05-10 TR TR96/00382A patent/TR199600382A2/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9609334A (pt) | 1999-05-25 |
| IL117997A0 (en) | 1996-10-31 |
| JPH10507203A (ja) | 1998-07-14 |
| PE34297A1 (es) | 1997-09-24 |
| EP0833823A1 (de) | 1998-04-08 |
| CA2220958A1 (en) | 1996-12-19 |
| MX9709980A (es) | 1998-03-29 |
| WO1996040660A1 (en) | 1996-12-19 |
| TR199600382A2 (tr) | 1996-12-21 |
| CO4700426A1 (es) | 1998-12-29 |
| AU5578796A (en) | 1996-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA23860A1 (fr) | Derives de benzylamine substitues se liant specifiquement aux recepteurs du neuropeptide y1 et compositions les contenant | |
| MA23961A1 (fr) | Benzylaminopiperidines substituees et compositions les contenant | |
| DZ2361A1 (fr) | Dérivés de 6-phénylpyridyl-2-amine et compositionspharmaceutiques les contenant | |
| ATE351910T1 (de) | Ob-fusionsprotein enthaltende zusammensetzungen und verfahren | |
| FR2743938B1 (fr) | Composant de protection d'interface de lignes telephoniques | |
| MA23895A1 (fr) | Amides therapeutiques et compositions les contenant | |
| BR9403948A (pt) | Composição de matéria | |
| BR9403946A (pt) | Composição de matéria | |
| FR2740682B1 (fr) | Composition topique contenant de la capsazepine | |
| ATE274260T1 (de) | Verfahren und gerät zum erhöhen der empfängerimmunität gegenüber störsignalen | |
| DE69631056D1 (de) | Zusammensetzungen von süssigkeiten | |
| DE4391813T1 (de) | Zusammensetzung aus plastifiziertem Gips | |
| LV10084A (lv) | Panemiens senisu apkarosanai fungicidie savienojumi to iegusanas panemiens un tadus savienojumus saturosais sastavs | |
| ATE230974T1 (de) | Neuropeptid y rezeptor antagonisten enthaltende kosmetische zusammensetzung | |
| EP0752048A4 (de) | Bohrloch-zementierungszusammensetzungen aus schlacke und verfahren zu deren herstellung | |
| DE69616396D1 (de) | Benzothiophen-Verbindungen, Zwischenprodukte, Zusammensetzungen und Verfahren | |
| ITMI950023A0 (it) | Composizioni termoplastiche compredenti amido ed altre componenti di origine naturale | |
| ID22389A (id) | Komposisi dan metode untuk menurunkan hipertensi okuler | |
| PL325469A1 (en) | Cleaning composition and method of giving extensive viscosity to cleaning compositions | |
| PT699069E (pt) | Antagonistas dos receptores de endotelina | |
| DE69610871D1 (de) | Biozide Zusammensetzungen bestehend aus Mischungen aus Halopropynylverbindungen und Schwefel enthaltende Triazine | |
| BR9305567A (pt) | Composição de poli-oxi-metileno | |
| PL311266A1 (en) | Application of indole derivatives as 5ht1 antagonists | |
| FR2762445B1 (fr) | Composant de protection d'interface de lignes telephoniques | |
| KR950700721A (ko) | 순한 샴푸 조성물(mild shampoo compositions) |